|Systematic (IUPAC) name|
|Oral, IV, topical|
|Protein binding||50 to 55%|
|Half-life||5.6 to 9 hours|
|Excretion||Renal and biliary|
|A01 D06 J01 S01 QG51 QJ51|
|(what is this?)|
Chlortetracycline (trade name Aureomycin, Lederle) is a tetracycline antibiotic, the first tetracycline to be identified. It was discovered in 1945 by Benjamin Minge Duggar working at Lederle Laboratories under the supervision of Yellapragada Subbarow. Duggar identified the antibiotic as the product of an actinomycete he cultured from a soil sample collected from Sanborn Field at the University of Missouri. The organism was named Streptomyces aureofaciens and the isolated drug, Aureomycin, because of their golden color.
- Jukes, Thomas H. Some historical notes on chlortetracycline. Reviews of Infectious Diseases 7(5):702-707 (1985).
- Merck Veterinary Manual.
|This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it.|
|This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.|
|This dermatologic drug article is a stub. You can help Wikipedia by expanding it.|